S. Xiang

Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors

L. Shen, Jian Li, S. Qin, 2021, Journal of Hematology & Oncology.

Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors

Toshio Shimizu, K. Yonemori, T. Koyama, 2022, Investigational New Drugs.

759P Preconditioning with irradiation enhances efficacy of B7-H3-CAR-T in treating solid tumor models

T. Wang, H. Wu, B. Zhang, 2022, Annals of Oncology.

A SINGLE‐ARM, OPEN‐LABEL, PILOT TRIAL OF AUTOLOGOUS CD7‐CAR‐T CELLS FOR CD7 POSITIVE RELAPSED AND REFRACTORY T‐LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

X. Wang, Zhaoming Li, G. Pan, 2021, Hematological Oncology.

Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.

Weijian Guo, L. Shen, Jian Li, 2020 .